Prudential PLC Buys 10,691 Shares of CVS Health Corporation $CVS

Prudential PLC grew its stake in shares of CVS Health Corporation (NYSE:CVS) by 58.9% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 28,856 shares of the pharmacy operator’s stock after buying an additional 10,691 shares during the quarter. Prudential PLC’s holdings in CVS Health were worth $1,990,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CVS. Avion Wealth boosted its holdings in shares of CVS Health by 99.0% in the 2nd quarter. Avion Wealth now owns 380 shares of the pharmacy operator’s stock worth $26,000 after purchasing an additional 189 shares in the last quarter. Harbor Asset Planning Inc. bought a new stake in shares of CVS Health in the 2nd quarter worth approximately $30,000. Bell Investment Advisors Inc boosted its stake in shares of CVS Health by 119.8% in the 1st quarter. Bell Investment Advisors Inc now owns 455 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 248 shares in the last quarter. Roxbury Financial LLC grew its holdings in shares of CVS Health by 78.3% during the 2nd quarter. Roxbury Financial LLC now owns 460 shares of the pharmacy operator’s stock valued at $32,000 after purchasing an additional 202 shares during the last quarter. Finally, ORG Partners LLC raised its position in CVS Health by 418.9% in the 2nd quarter. ORG Partners LLC now owns 467 shares of the pharmacy operator’s stock worth $32,000 after purchasing an additional 377 shares during the period. Institutional investors own 80.66% of the company’s stock.

Analyst Ratings Changes

CVS has been the topic of a number of recent research reports. Truist Financial reaffirmed a “buy” rating and set a $95.00 price objective (up from $92.00) on shares of CVS Health in a research note on Thursday, October 30th. Weiss Ratings restated a “hold (c-)” rating on shares of CVS Health in a research report on Monday, November 17th. UBS Group boosted their price objective on CVS Health from $79.00 to $96.00 and gave the company a “buy” rating in a research report on Friday, October 24th. Wolfe Research raised their target price on shares of CVS Health from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Monday, September 22nd. Finally, Royal Bank Of Canada upped their price target on shares of CVS Health from $81.00 to $93.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty-one have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $89.41.

CVS Health Trading Up 2.5%

Shares of CVS opened at $77.92 on Friday. CVS Health Corporation has a 1-year low of $43.56 and a 1-year high of $85.15. The company has a current ratio of 0.83, a quick ratio of 0.62 and a debt-to-equity ratio of 0.83. The firm’s 50-day moving average price is $78.12 and its 200-day moving average price is $70.28. The firm has a market capitalization of $98.91 billion, a price-to-earnings ratio of 205.06, a PEG ratio of 0.87 and a beta of 0.60.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Wednesday, October 29th. The pharmacy operator reported $1.60 EPS for the quarter, topping the consensus estimate of $1.36 by $0.24. CVS Health had a net margin of 0.12% and a return on equity of 11.45%. The business had revenue of $102.87 billion during the quarter, compared to analyst estimates of $98.85 billion. During the same period last year, the business posted $1.09 earnings per share. CVS Health’s quarterly revenue was up 7.8% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. Sell-side analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Monday, November 3rd. Investors of record on Thursday, October 23rd were paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.4%. The ex-dividend date of this dividend was Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 700.00%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.